Medtronic plc(MDT)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
MDT | 121.04 B | 23.25x | 13.70% | 13.93% | $4.07 | 10.65% | 0.55x | 3.01% | $106.33 | $73.31 |
STE | 21.96 B | 27.53x | 7.30% | 13.33% | $8.18 | 11.39% | 0.28x | 1.13% | $267.14 | $193.97 |
TRIB | 6.3 M | - | - | -85.36% | -$60.00 | - | - | 0.00% | $52.50 | $5.01 |
HBCN.IR | - | - | - | - | - | - | - | - | - | - |
Peer Valuation & Performance Analysis
Peer group analysis for Medtronic plc (MDT) compared to its primary competitors (including STE, TRIB, HBCN.IR) reveals distinct metrics. MDT trades at a valuation premium compared to its competitors, with a P/E ratio of 23.3x versus the peer average of 13.7x (representing a 70% premium). This indicates that the market expects superior growth or commands a quality premium for MDT. In terms of growth, MDT's revenue growth of 13.7% exceeds the peer average of 7.3%, highlighting its competitive strength and market share gains. Additionally, it boasts superior profitability with a net margin of 13.9% compared to the peer average of -36.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• MDT ranks #1 in P/E ratio, #1 in revenue growth, and #1 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $93.53 | $94.92 | $93.42 | $94.63 | 14,847,333 | +2.00% |
| 2026-10-19 | $93.80 | $94.80 | $92.67 | $92.77 | 23,011,800 | -2.09% |
| 2026-10-16 | $95.83 | $96.50 | $94.26 | $94.75 | 30,274,700 | -0.73% |
| 2026-10-15 | $95.00 | $96.24 | $93.96 | $95.45 | 50,229,700 | +1.29% |
| 2026-10-14 | $93.01 | $94.72 | $92.16 | $94.23 | 49,858,700 | +1.31% |
| 2026-10-13 | $92.35 | $93.01 | $90.20 | $93.01 | 24,930,900 | +1.17% |
| 2026-10-12 | $90.76 | $92.87 | $90.71 | $91.93 | 36,562,600 | +3.90% |
| 2026-10-09 | $88.49 | $89.81 | $87.40 | $88.48 | 38,861,800 | +0.83% |
| 2026-10-08 | $85.90 | $88.48 | $85.55 | $87.75 | 105,664,000 | +2.62% |
| 2026-10-07 | $87.40 | $88.19 | $85.43 | $85.51 | 55,891,000 | -1.81% |
| 2026-10-06 | $87.97 | $88.50 | $86.45 | $87.09 | 52,133,800 | -1.00% |
| 2026-10-05 | $86.33 | $88.12 | $85.53 | $87.97 | 43,693,700 | +1.84% |
| 2026-10-02 | $86.55 | $87.94 | $85.59 | $86.38 | 35,364,700 | -0.07% |
| 2026-10-01 | $85.85 | $86.84 | $85.22 | $86.44 | 29,277,400 | +0.17% |
| 2026-09-30 | $86.57 | $87.42 | $86.20 | $86.29 | 26,614,100 | -0.92% |
Explore More Analysis for MDT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.